Barbara Brenner on KQED Perspectives
On February 4th, Executive Director Barbara Brenner was featured on KQED as part of their Perspectives series. The focus of her segment is on why you should never call her a breast cancer 'survivor.'
Click here to listen to Barbara's perspective (approximately two minutes long).
In the News: Aspirin and ESAs
At Breast Cancer Action, we've noticed before the possible benefits of aspirin to reduce the risk of developing breast cancer. Now a new study points to the possible benefits of aspirin for reducing the risk of dying from breast cancer. Read all about it here.
ESAs (Erythropoiesis-Stimulating Agents) - drugs like Procrit, Epogen and Aranesp are back in the news. In 2008, when the FDA first addressed safety concerns about these drugs for cancer patients, BCA urged the agency to remove the drugs from the market. Instead, the agency issued warnings about the use of these drugs in cancer patients. On February 16, 2010, the FDA issued additional requirements to ensure that these drugs are safely used. Read about it here.
BCA Welcomes New Board Members
Breast Cancer Action welcomes new board members Lauri Andress, Catherine DeLorey, Marla Stein, Tracy Weitz, and Marilyn Zivian. Find out more about these remarkable women who recently joined our Board of Directors.
BCA applauds outgoing board members Diane Carr, Dorothy Geoghegan, JoAnn Loulan, and Bhavna Shamasunder for their years of leadership, vision, and unending commitment to inspire and compel the changes necessary to end the breast cancer epidemic. Their clear voices have made BCA a stronger, more diverse and responsive organization during their years of service.
BCA Champions Wall
BCA wants to thank people for their work, support and stand regarding breast cancer. Send us the names of those you want to publicly recognize. Without all of you, our work wouldn't be possible.
Do you have someone you'd like to thank? Click here to add them to our wall.
The Winter Issue of The Source Is Now Available Online!
Sign up here to receive The Source directly to your inbox four times a year.
In this issue:
New Study Points to Problems with Breast Cancer Screening
A BCA Summer Intern's Story: An Interview with Alice Price-Styles
On Being Diagnosed with Breast Cancer
The "Scientific" Argument for Cheer: An Excerpt from Barbara Ehrenreich's new book, Bright-Sided: How the Relentless Promotion of Positive Thinking Has Undermined America
USPSTF Releases New Screening Guidelines
Mammography screening is in the news again. The US Prevention Services Task Force has announced new guidelines for breast cancer screening that would mean women get fewer mammograms. This is good news.
Read BCA’s analysis of the new recommendations here. On the issue of prevention, click here for information on why words matter.
Think Before You Pink wins 2009 BENNY Award
BCA's victorious 2008 Think Before You Pink campaign, "Yoplait: Put a Lid on it" won the first place 2009 BENNY Award from the Business Ethics Network. The annual BENNY Awards recognize outstanding corporate campaign victories. Learn about the campaign here.
Eli Lilly is Milking Cancer
BCA is targeting Eli Lilly with this year's Think Before You Pink campaign.
Eli Lilly is now the sole manufacturer of rBGH — the artificial growth hormone given to dairy cows that increases people’s risk of cancer. Eli Lilly also manufactures breast cancer treatment medications and a pill that “reduces the risk” of breast cancer. It's a perfect profit circle. Eli Lilly is milking cancer. Tell them to stop making rBGH.
BCA Victory at the FDA
BCA's testimony at the FDA helped to secure a victory for patients.
The Oncologic Drug Advisory Committee opposed Ortho Biotech’s request to approve Doxil for metastatic breast cancer. We will make sure the FDA Commissioner follows the committee’s recommendation. Read BCA's statement here.
Breast Cancer Action Sues to End Gene Patenting
BCA is a plaintiff in a lawsuit filed on May 12, challenging Myriad Genetics' patents on BRCA1 and BRCA2, the “breast cancer genes.”
Read our press release to learn more about the case and why BCA joined it.
BCA is the only breast cancer organization involved in the suit because we are the watchdogs of the breast cancer movement and we don't take money from companies that profit from or contribute to cancer.
Your support makes this important work possible!
CA Safe Cosmetics Program Implemented
The California Safe Cosmetics Act, which BCA cosponsored and helped to pass in 2005, has finally begun implementation! Cosmetics manufacturers are now required to report any ingredients in their products known or suspected to cause cancer, birth defects, or other reproductive harm. Learn more about the California Safe Cosmetics Program.